This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Lannett Company
LCI
0,59 €
Share price
0.00%
Change (1 day)
-71.85%
Change (1 year)
Categories
Earnings for Lannett Company (LCI)
Earnings in 2023 (TTM): -€0.19 Billion
According to Lannett Company's latest financial reports the company's current earnings are €0.31 Billion. In 2022 the company made an earning of -€0.12 Billion a decrease over its 2021 earnings that were of -€94.09 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Lannett Company from 2000 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -€0.19 Billion | 61.26% |
| 2022 | -€0.12 Billion | 23.09% |
| 2021 | -€94.09 Million | -51.41% |
| 2020 | -€0.2 Billion | -424.46% |
| 2019 | €59.67 M | -126.23% |
| 2018 | -€0.23 Billion | -255.9% |
| 2017 | €0.14 B | 170.58% |
| 2016 | €53.94 M | -66.69% |
| 2015 | €0.16 B | -4.54% |
| 2014 | €0.16 B | 619.53% |
| 2013 | €23.57 M | 80.15% |
| 2012 | €13.08 M | -908.06% |
| 2011 | -€1.62 Million | -118.48% |
| 2010 | €8.76 M | -17.12% |
| 2009 | €10.57 M | 453.37% |
| 2008 | €1.91 M | -119.89% |
| 2007 | -€9.62 Million | -239.11% |
| 2006 | €6.9 M | -115.19% |
| 2005 | -€45.48 Million | -532.64% |
| 2004 | €10.51 M | -47.76% |
| 2003 | €20.12 M | 41.23% |
| 2002 | €14.24 M | 165.35% |
| 2001 | €5.36 M | 5002.96% |
| 2000 | €0.1 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | €8.95 B | -5,314.59% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €23.72 B | -13,920.86% | 🇺🇸 USA |
 Abbott Laboratories ABT | €6.36 B | -3,808.86% | 🇺🇸 USA |
 Novartis NVS | €12.91 B | -7,622.60% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | €4.68 B | -2,826.46% | 🇬🇧 UK |